InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

RCUS Insider Trading

Insider Ownership Percentage: 12.30%
Insider Buying (Last 12 Months): $319,999,995.00
Insider Selling (Last 12 Months): $1,577,199.69

Arcus Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Arcus Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arcus Biosciences Share Price & Price History

Current Price: $14.28
Price Change: ▼ Price Decrease of -0.34 (-2.33%)
As of 11/21/2024 05:34 PM ET

This chart shows the closing price history over time for RCUS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This company will win the AI race
From Porter & Company   |   Ad
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
You must read this new presentation from Porter Stansberry.

Arcus Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05215,253View SEC Filing Icon  
3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08226,804View SEC Filing Icon  
2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85274,323View SEC Filing Icon  
2/26/2024Juan C. JaenPresidentSell3,900$20.06$78,234.001,211,365View SEC Filing Icon  
1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.0030,061,124View SEC Filing Icon  
1/2/2024Juan C. JaenPresidentSell6,975$20.09$140,127.751,215,265View SEC Filing Icon  
1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.0051,831View SEC Filing Icon  
12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96258,878View SEC Filing Icon  
9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31302,691View SEC Filing Icon  
7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00336,566View SEC Filing Icon  
7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.3811,596View SEC Filing Icon  
6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.0014,823,029View SEC Filing Icon  
6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44381,566View SEC Filing Icon  
6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05394,003View SEC Filing Icon  
3/16/2023Jennifer JarrettCOOSell8,729$16.81$146,734.49406,217View SEC Filing Icon  
1/26/2023Jennifer JarrettCOOSell300$23.56$7,068.00416,546View SEC Filing Icon  
12/16/2022Carolyn C TangGeneral CounselSell2,523$30.75$77,582.2528,584View SEC Filing Icon  
12/16/2022Jennifer JarrettCOOSell16,482$30.75$506,821.50147,609View SEC Filing Icon  
12/16/2022Juan C. JaenPresidentSell4,436$30.75$136,407.00218,258View SEC Filing Icon  
12/16/2022Robert C Goeltz IICFOSell2,453$30.75$75,429.7511,566View SEC Filing Icon  
12/16/2022Terry J. RosenCEOSell13,043$30.75$401,072.25242,173View SEC Filing Icon  
9/16/2022Jennifer JarrettCOOSell12,677$26.28$333,151.56130,942View SEC Filing Icon  
6/16/2022Carolyn C TangGeneral CounselSell1,400$20.72$29,008.0025,431View SEC Filing Icon  
6/16/2022Jennifer JarrettCOOSell6,081$20.72$125,998.32125,233View SEC Filing Icon  
6/16/2022Juan C. JaenPresidentSell2,333$20.72$48,339.76212,574View SEC Filing Icon  
6/16/2022Terry J. RosenCEOSell4,241$20.72$87,873.52232,329View SEC Filing Icon  
3/16/2022Jennifer JarrettCOOSell9,617$31.62$304,089.54View SEC Filing Icon  
12/20/2021Jennifer JarrettCOOSell34,822$41.48$1,444,416.56View SEC Filing Icon  
12/16/2021Carolyn C TangGeneral CounselSell487$39.82$19,392.34View SEC Filing Icon  
12/16/2021Jennifer JarrettCOOSell5,560$39.82$221,399.20View SEC Filing Icon  
12/16/2021Juan C. JaenPresidentSell865$39.82$34,444.30View SEC Filing Icon  
12/16/2021Robert C Goeltz IICFOSell485$39.83$19,317.55View SEC Filing Icon  
12/16/2021Terry J. RosenCEOSell2,299$39.82$91,546.18View SEC Filing Icon  
See Full Table
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

92.89% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCUS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arcus Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC1,222,206$18.69M0.0%-0.9%1.336%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC118,693$1.82M0.0%+49.0%0.130%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd23,581$0.36M0.0%+100.6%0.026%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd11,195$0.17M0.0%-71.1%0.012%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC217,041$3.32M0.0%+59.8%0.237%Search for SEC Filing on Google Icon
11/15/2024State Street Corp3,011,174$46.04M0.0%-1.4%3.291%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd3,946$60K0.0%-27.7%0.004%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.2,437,073$37.26M0.1%+32.9%2.663%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC1,025,754$15.68M2.0%+146.9%1.121%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.20,347$0.31M0.1%-23.7%0.022%Search for SEC Filing on Google Icon
11/15/2024Point72 Hong Kong Ltd3,100$47K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC87,636$1.34M0.1%+19.6%0.096%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC238,544$3.65M0.0%N/A0.261%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P16,426$0.25M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/14/2024Suvretta Capital Management LLC663,603$10.15M0.3%-30.7%0.725%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC69,886$1.07M0.0%-27.8%0.076%Search for SEC Filing on Google Icon
11/14/2024PEAK6 Investments LLC15,000$0.23M0.0%-40.0%0.016%Search for SEC Filing on Google Icon
11/14/2024Public Sector Pension Investment Board114,399$1.75M0.0%-4.7%0.125%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 30,781$0.47M0.0%+2.8%0.034%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets11,325$0.17M0.0%-46.5%0.012%Search for SEC Filing on Google Icon
11/13/2024FMR LLC4,467,557$68.31M0.0%+6.9%4.882%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd35,053$0.54M0.1%+97.8%0.038%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC112,847$1.73M0.0%+48.0%0.123%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.566,979$8.67M0.0%+11.7%0.620%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA80,889$1.24M0.0%+39.0%0.088%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC15,959$0.24M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.931,048$14.24M0.0%+25.1%1.018%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC9,431$0.14M0.0%+40,904.3%0.010%Search for SEC Filing on Google Icon
11/7/2024Thrivent Financial for Lutherans42,360$0.65M0.0%-6.5%0.046%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.48,482$0.74M0.0%-2.5%0.053%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP187,415$2.87M0.2%+17.8%0.205%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.255,611$3.91M0.0%-6.8%0.280%Search for SEC Filing on Google Icon
10/25/2024New York State Teachers Retirement System94,251$1.44M0.0%-5.0%0.104%Search for SEC Filing on Google Icon
10/24/2024State of Alaska Department of Revenue30,783$0.47M0.0%-3.9%0.034%Search for SEC Filing on Google Icon
10/23/2024Louisiana State Employees Retirement System26,100$0.40M0.0%-5.1%0.029%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC11,924$0.18M0.0%-6.9%0.013%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC9,909$0.15M0.0%-16.5%0.011%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB22,300$0.34M0.0%+15.5%0.024%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC30,069$0.46M0.0%-76.7%0.033%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd5,461$83K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC76,257$1.16M0.0%+30.9%0.083%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company29,858$0.46M0.0%+7.7%0.033%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC24,524$0.37M0.0%+67.9%0.027%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.26,677$0.41M0.1%N/A0.029%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC16,700$0.25M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.1,833,851$27.93M0.1%-4.2%2.006%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC84,463$1.29M0.0%N/A0.092%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd5,461$83K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/14/2024Public Sector Pension Investment Board120,099$1.83M0.0%+7.4%0.131%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC19,737$0.30M0.0%-63.7%0.022%Search for SEC Filing on Google Icon
8/13/2024Thrivent Financial for Lutherans45,303$0.69M0.0%-3.4%0.050%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd38,761$0.59M0.1%N/A0.043%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank16,184$0.25M0.0%-6.7%0.018%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC82,400$1.26M0.0%-65.7%0.091%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP1,479,627$22.54M0.0%-8.7%1.627%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA58,173$0.89M0.0%+3.5%0.064%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd59,137$0.90M0.1%+3.3%0.065%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.70,917$1.08M0.0%+22.5%0.078%Search for SEC Filing on Google Icon
8/7/2024ClariVest Asset Management LLC17,092$0.26M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/7/2024Texas Permanent School Fund Corp40,460$0.62M0.0%-14.1%0.044%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.49,702$0.76M0.0%-34.0%0.055%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers165,835$2.53M0.0%-4.0%0.182%Search for SEC Filing on Google Icon
7/30/2024Maryland State Retirement & Pension System19,027$0.29M0.0%-3.7%0.021%Search for SEC Filing on Google Icon
7/30/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.744,298$11.34M0.0%+8.7%0.818%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.274,388$4.18M0.0%-5.4%0.302%Search for SEC Filing on Google Icon
7/29/2024Innealta Capital LLC4,338$66K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.245,607$3.74M0.0%-37.1%0.270%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp395,866$6.03M0.0%-1.1%0.435%Search for SEC Filing on Google Icon
7/24/2024Louisiana State Employees Retirement System27,500$0.42M0.0%+2.6%0.030%Search for SEC Filing on Google Icon
7/16/2024Diversified Trust Co13,545$0.21M0.0%+12.1%0.015%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC129,292$1.97M0.0%+1,396.1%0.142%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank22,399$0.42M0.0%-10.9%0.025%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System49,157$0.93M0.0%-5.4%0.054%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD34,764$0.66M0.0%+5.8%0.038%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.4,791,244$90.46M0.0%+2.4%5.268%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System17,492$0.32M0.0%+16.1%0.019%Search for SEC Filing on Google Icon
5/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.685,025$12.93M0.0%+26.9%0.753%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC10,846$0.21M0.0%+7.4%0.012%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC3,139$59K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC8,642$0.16M0.0%-58.0%0.010%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB259,372$4.89M0.0%+26.3%0.285%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets35,640$0.67M0.0%-67.7%0.039%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.32,356$0.58M0.0%+5.6%0.036%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC12,940$0.24M0.0%+9.2%0.014%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.289,965$5.48M0.0%-12.9%0.319%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC24,639$0.47M0.0%-9.1%0.027%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.39,731$0.75M0.0%-15.9%0.044%Search for SEC Filing on Google Icon
4/23/2024Spartan Fund Management Inc.2,000$38K0.1%N/A0.002%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC12,940$0.24M0.0%+9.2%0.014%Search for SEC Filing on Google Icon
4/18/2024Diversified Trust Co12,078$0.23M0.0%N/A0.013%Search for SEC Filing on Google Icon
4/5/2024GAMMA Investing LLC2,427$46K0.0%+51.6%0.003%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.1,507$29K0.0%-61.4%0.002%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.4,680,716$89.40M0.0%+4.2%5.152%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP1,868,000$35.68M5.7%-5.1%2.495%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC247,664$4.73M0.7%+20.7%0.331%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP23,700$0.45M0.1%N/A0.032%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.97,435$1.86M0.8%-74.0%0.130%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC2,514$48K0.0%-47.4%0.003%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC251,404$4.80M0.0%-14.1%0.336%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC11,141$0.21M0.0%N/A0.015%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arcus Biosciences logo
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.
Read More on Arcus Biosciences

Today's Range

Now: $14.28
Low: $14.15
High: $14.71

50 Day Range

MA: $16.49
Low: $14.44
High: $18.44

52 Week Range

Now: $14.28
Low: $13.49
High: $20.31

Volume

676,147 shs

Average Volume

732,910 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Arcus Biosciences?

Arcus Biosciences' top insider shareholders include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Juan C Jaen (President)
  3. Jennifer Jarrett (COO)
  4. Terry J Rosen (CEO)
  5. Robert C Goeltz II (CFO)
  6. Carolyn C Tang (General Counsel)
  7. Alexander Azoy (CAO)
Learn More about top insider investors at Arcus Biosciences.

Who are the major institutional investors of Arcus Biosciences?

Arcus Biosciences' top institutional shareholders include:
  1. FMR LLC — 4.88%
  2. State Street Corp — 3.29%
  3. Point72 Asset Management L.P. — 2.66%
  4. Geode Capital Management LLC — 1.34%
  5. Parkman Healthcare Partners LLC — 1.12%
  6. BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 1.02%
Learn More about top institutional investors of Arcus Biosciences stock.

Which major investors are selling Arcus Biosciences stock?

In the previous quarter, RCUS stock was sold by these institutional investors:
  1. Suvretta Capital Management LLC
  2. SG Americas Securities LLC
  3. State Street Corp
  4. XTX Topco Ltd
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. Principal Financial Group Inc.
  7. Geode Capital Management LLC
  8. PEAK6 Investments LLC
Within the previous year, company insiders that have sold Arcus Biosciences company stock include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Juan C Jaen (President)
  3. Jennifer Jarrett (COO)
Learn More investors selling Arcus Biosciences stock.

Which major investors are buying Arcus Biosciences stock?

During the previous quarter, RCUS stock was bought by institutional investors including:
  1. Parkman Healthcare Partners LLC
  2. Point72 Asset Management L.P.
  3. FMR LLC
  4. Walleye Capital LLC
  5. BNP PARIBAS ASSET MANAGEMENT Holding S.A.
  6. Jane Street Group LLC
  7. Charles Schwab Investment Management Inc.
  8. Barclays PLC
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.